Why is Remedium Life falling/rising?

As of 05-Jun, Remedium Lifecare Ltd's stock price is currently at 1.43, reflecting a decrease of 0.07, or 4.67%. The stock has been on a downward trend, having underperformed its sector by 6.5% today and experiencing a consecutive fall for the last seven days, resulting in a total decline of 22.7% during this period. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish technical trend. The company has reported significant financial challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed, and a drastic decline in net sales and profits over the past year, contributing to the stock's poor performance.
In the broader market context, while the Sensex has shown a slight increase of 0.80% over the past month, Remedium Lifecare Ltd has seen a substantial decline of 21.43% in the same timeframe, highlighting its significant underperformance relative to the benchmark. The stock's year-to-date performance is particularly concerning, with a staggering drop of 59.99%, contrasting sharply with the Sensex's gain of 4.23%. This stark difference underscores the challenges faced by Remedium Lifecare Ltd, as it continues to struggle with liquidity issues and a lack of investor confidence, further exacerbating its negative trajectory in the market.